FDA label
What is Rocklatan used for?
Rocklatan contains netarsudil and latanoprost. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “ROCKLATAN is a fixed dose combination of a Rho kinase inhibitor and a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Rocklatan?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Rocklatan, solution/ drops
Indications and Usage, quoted from the label by Alcon Laboratories, Inc. (NDA208259). Cross-references to other label sections are left out.
ROCKLATAN is a fixed dose combination of a Rho kinase inhibitor and a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Source: DailyMed label, set id b1d71f41-be06-4a08-94d4-e352198f09c2, version 15, effective August 27, 2026. NDC 70727-529, one of 1 listing for this product.
Questions
What is Rocklatan used for?
The FDA label says: “ROCKLATAN is a fixed dose combination of a Rho kinase inhibitor and a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.”
What drug class is Rocklatan?
FDA lists netarsudil and latanoprost in the Rho Kinase Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.